Changes in Radiosensitivity to Gamma-Rays of Lymphocytes from Hyperthyroid Patients Treated with I-131.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Sep 2022
Historique:
received: 18 07 2022
revised: 17 08 2022
accepted: 27 08 2022
entrez: 9 9 2022
pubmed: 10 9 2022
medline: 14 9 2022
Statut: epublish

Résumé

This study investigated the peripheral blood lymphocytes (PBL) response to a dose of γ-rays in patients treated with radioiodine (I-131) for hyperthyroidism vs. healthy controls, to gain information about the individual lymphocytes' radio-sensitivity. Blood samples were taken from 18 patients and 10 healthy donors. Phosphorylated histone variant H2AX (γ-H2AX) and micronuclei (MN) induction were used to determine the change in PBL radio-sensitivity and the correlations between the two types of damage. The two assays showed large inter-individual variability in PBL background damage and in radio-sensitivity (patients vs. healthy donors). In particular, they showed an increased radio-sensitivity in 36% and 33% of patients, decrease in 36% and 44%, respectively. There was a scarce correlation between the two assays and no dependence on age or gender. A significant association was found between high radio-sensitivity conditions and induced hypothyroidism. PBL radio-sensitivity in the patient group was not significantly affected by treatment with I-131, whereas there were significant changes inter-individually. The association found between clinical response and PBL radio-sensitivity suggests that the latter could be used in view of the development of personalized treatments.

Identifiants

pubmed: 36077557
pii: ijms231710156
doi: 10.3390/ijms231710156
pmc: PMC9456272
pii:
doi:

Substances chimiques

Iodine Radioisotopes 0
Iodine-131 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mutagenesis. 2017 Mar 1;32(2):267-273
pubmed: 27831478
Eur Heart J. 2012 Feb;33(3):408-14
pubmed: 21862464
J Nucl Med. 2016 Feb;57(2):173-9
pubmed: 26564321
N Engl J Med. 2011 Feb 10;364(6):542-50
pubmed: 21306240
Mutat Res. 2013 Apr-Jun;752(2):84-98
pubmed: 23262375
J Nucl Med. 2015 Apr;56(4):505-11
pubmed: 25722453
PLoS One. 2011;6(9):e25113
pubmed: 21966430
Mutat Res. 2012 Oct-Dec;751(2):258-286
pubmed: 22677531
Mutagenesis. 2011 Jan;26(1):111-7
pubmed: 21164191
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Environ Mol Mutagen. 2007 Jan;48(1):38-47
pubmed: 17163504
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Health Phys. 1991 Nov;61(5):623-30
pubmed: 1752745
Mutat Res. 2000 Nov 20;455(1-2):81-95
pubmed: 11113469
Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2218-28
pubmed: 20625722
Genome Integr. 2018 May 31;9:2
pubmed: 30820313
Endocrinol Metab (Seoul). 2016 Mar;31(1):168-73
pubmed: 26996425
Radiat Environ Biophys. 2015 May;54(2):183-94
pubmed: 25636513
Thyroid. 2011 Jun;21(6):593-646
pubmed: 21510801
Radiat Res. 2011 Aug;176(2):139-57
pubmed: 21631286
Adv Space Res. 2003;31(6):1543-51
pubmed: 12971409
Eur J Endocrinol. 2009 Nov;161(5):771-7
pubmed: 19671708
Nuklearmedizin. 2011;50(3):93-9; quiz N20
pubmed: 21165539
Int J Radiat Biol. 2018 Jan;94(1):54-61
pubmed: 29095072
Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1712-9
pubmed: 22854986
Cancer Lett. 2012 Dec 31;327(1-2):123-33
pubmed: 22198208
Mutagenesis. 2011 Jan;26(1):101-6
pubmed: 21164189
Mutat Res Genet Toxicol Environ Mutagen. 2019 Feb;838:59-66
pubmed: 30678829
Dose Response. 2015 Nov 19;13(4):1559325815611904
pubmed: 26740810
Indian J Endocrinol Metab. 2014 Sep;18(5):648-54
pubmed: 25285281
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1126-34
pubmed: 23576099
J Nucl Med. 2010 Aug;51(8):1318-25
pubmed: 20660387
Mutagenesis. 2011 Jan;26(1):11-7
pubmed: 21164177
Nucleic Acids Res. 2007;35(5):e36
pubmed: 17284459
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
J Nucl Med. 2000 Jan;41(1):17-22
pubmed: 10647600

Auteurs

Valentina Dini (V)

National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Istituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma1, Department of Physics, University La Sapienza, 00185 Rome, Italy.

Massimo Salvatori (M)

Nuclear Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Maria Elena Lago (ME)

Nuclear Medicine Unit, ARNAS Garibaldi-P.O. Nesima, 95122 Catania, Italy.

Donatella Pia Dambra (DP)

Associazione Donatori Sangue "La Rete di Tutti", 00145 Rome, Italy.

Luisa Lo Conte (L)

Nuclear Medicine Unit, "Vito Fazzi" Hospital, 73100 Lecce, Italy.

Ilaria Pecchia (I)

National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Alessandro Giordano (A)

Nuclear Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH